scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1026801916 |
P356 | DOI | 10.1038/GENE.2008.14 |
P698 | PubMed publication ID | 18354419 |
P5875 | ResearchGate publication ID | 5498884 |
P50 | author | Françoise Clerget-Darpoux | Q30501400 |
Marie-Claude Babron | Q30501401 | ||
Stephan Ripke | Q56959255 | ||
P2093 | author name string | S Lutz | |
B Müller-Myhsok | |||
B Fontaine | |||
F Holsboer | |||
M Uhr | |||
A Kroner | |||
P Rieckmann | |||
F Weber | |||
G Edan | |||
M Kohli | |||
M Ising | |||
I Cournu-Rebeix | |||
D Brassat | |||
S Mrejen | |||
M Clanet | |||
J Yaouanq | |||
T Bettecken | |||
G Semana | |||
O Lyon-Caen | |||
F Müller-Sarnowski | |||
M Knop | |||
C Gout | |||
P2860 | cites work | The prevalence of multiple sclerosis in the world: an update | Q22252675 |
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis | Q22252943 | ||
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment | Q28295248 | ||
Risk alleles for multiple sclerosis identified by a genomewide study | Q29614890 | ||
New diagnostic criteria for multiple sclerosis: guidelines for research protocols | Q34271601 | ||
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis | Q34388729 | ||
The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures | Q34556417 | ||
Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis | Q34657157 | ||
Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. | Q34733337 | ||
ReviewDoes the “Hygiene Hypothesis” Provide an Explanation for the High Prevalence of Multiple Sclerosis in Sardinia? | Q35563668 | ||
Multiple sclerosis genetics: leaving no stone unturned | Q36171871 | ||
Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells | Q36367031 | ||
Multiple sclerosis: postlinkage genetics | Q36368900 | ||
A new era in the genetic analysis of multiple sclerosis | Q36479910 | ||
Genetic susceptibility to MS: a second stage analysis in Canadian MS families | Q40689518 | ||
Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells | Q44479232 | ||
Haplotypes of the interleukin 7 receptor alpha gene are correlated with altered expression in whole blood cells in multiple sclerosis. | Q46956244 | ||
IL2RA/CD25 polymorphisms contribute to multiple sclerosis susceptibility. | Q50699339 | ||
Familial recurrence rates and genetic models of multiple sclerosis. | Q51976787 | ||
Pedigree disequilibrium tests for multilocus haplotypes. | Q52010978 | ||
Variation in interleukin 7 receptor α chain (IL7R) influences risk of multiple sclerosis | Q56681076 | ||
Susceptibility to multiple sclerosis: the role of interleukin genes | Q56681077 | ||
A full genome search in multiple sclerosis | Q57264092 | ||
Genomewide Study of Multiple Sclerosis | Q57912329 | ||
Are genome-wide association studies all that we need to dissect the genetic component of complex human diseases? | Q58485757 | ||
Are Linkage Analysis and the Collection of Family Data Dead? Prospects for Family Studies in the Age of Genome-Wide Association | Q58485762 | ||
Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis | Q59649507 | ||
Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis | Q73065874 | ||
Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group | Q74785782 | ||
Old suspects found guilty--the first genome profile of multiple sclerosis | Q80693902 | ||
Multiple sclerosis | Q81574168 | ||
P433 | issue | 3 | |
P921 | main subject | multiple sclerosis | Q8277 |
P304 | page(s) | 259-263 | |
P577 | publication date | 2008-03-20 | |
P1433 | published in | Genes and Immunity | Q15745246 |
P1476 | title | IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations | |
P478 | volume | 9 |
Q38380398 | Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis |
Q58200056 | Association between the IL7R T244I polymorphism and multiple sclerosis: a meta-analysis |
Q37005355 | Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis |
Q35875895 | Association study of four polymorphisms in the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran |
Q98169836 | Broadening our understanding of the genetics of Juvenile Idiopathic Arthritis (JIA): Interrogation of three dimensional chromatin structures and genetic regulatory elements within JIA-associated risk loci |
Q37083069 | CD226 Gly307Ser association with multiple autoimmune diseases |
Q35571261 | CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical Subtypes |
Q37903850 | Clinical and immunological features of celiac disease in patients with Type 1 diabetes mellitus |
Q38088728 | Clinical biomarkers in multiple sclerosis |
Q33630669 | Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci |
Q53080271 | Cytokine gene polymorphisms in multiple sclerosis: a meta-analysis of 45 studies including 7379 cases and 8131 controls. |
Q41342420 | Determination of the real effect of genes identified in GWAS: the example of IL2RA in multiple sclerosis |
Q60491636 | Do Human Endogenous Retroviruses Contribute to Multiple Sclerosis, and if So, How? |
Q34993579 | Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis |
Q36625351 | Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy |
Q28943261 | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis |
Q84193143 | HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain) |
Q58485745 | HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis |
Q41295973 | Heterogeneity in multiple sclerosis: scratching the surface of a complex disease. |
Q24599179 | IFIH1-GCA-KCNH7 locus is not associated with genetic susceptibility to multiple sclerosis in French patients |
Q86810148 | IL2RA Allele Increases Risk of Neuromyelitis Optica in Southern Han Chinese |
Q33396971 | IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production |
Q92589561 | IL7RA genetic variants differentially affect IL-7Rα expression and alternative splicing: a role in autoimmune and infectious diseases? |
Q47680353 | IL7RA haplotype-associated alterations in cellular immune function and gene expression patterns in multiple sclerosis. |
Q34083878 | Interleukin 2 receptor α gene polymorphism and risk of multiple sclerosis: a meta-analysis |
Q54439256 | Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans. |
Q36246917 | Interleukin-2 receptor-α proximal promoter hypomethylation is associated with multiple sclerosis |
Q37791489 | Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions |
Q37328815 | Multiple sclerosis and reproductive risks in women |
Q38079620 | Multiple sclerosis: individualized disease susceptibility and therapy response. |
Q37728003 | Pathogenic mechanisms and experimental models of multiple sclerosis |
Q38732011 | Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells. |
Q34329281 | Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk |
Q47687523 | Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis. |
Q57224463 | RGMA and IL21R show association with experimental inflammation and multiple sclerosis |
Q28238782 | Recent advances in the genetics of autoimmune disease |
Q46466235 | Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians |
Q57251791 | Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients |
Q37857943 | Risk conferring genes in multiple sclerosis |
Q24623113 | Shared and distinct genetic variants in type 1 diabetes and celiac disease |
Q83208728 | Shared susceptibility variations in autoimmune diseases: a brief perspective on common issues |
Q37990779 | Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers. |
Q37100271 | TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis. |
Q33737840 | Technologies in the Whole-Genome Age: MALDI-TOF-Based Genotyping |
Q41727268 | The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females. |
Q37994432 | The human IL-7 receptor gene: deletions, polymorphisms and mutations. |
Q36289774 | The single nucleotide variant rs12722489 determines differential estrogen receptor binding and enhancer properties of an IL2RA intronic region |
Q53808298 | Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population. |
Q36396476 | What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? |
Q41445038 | Where is the causal variant? On the advantage of the family design over the case-control design in genetic association studies |
Search more.